XTL BIOPHARMACEUTICALS LTD. Amended Reports
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-05-19: Form 20-F/A; Period of report 2020-12-31; Description AMENDMENT NO. 1 TO FORM 20-F; Document f20f2020a1_xtlbiopharma.htm.
- 2017-04-03: Form 20-F/A; Period of report 2016-12-31; Description 20-F/A; Document v463198_20fa.htm.
- 2012-06-11: Form 20-F/A; Period of report 2011-12-31; Description AMENDMENT NO. 2; Document v315524_20fa.htm.
- 2012-03-30: Form 20-F/A; Period of report 2011-12-31; Description FORM 20-F/A; Document v308027_20fa.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-05-19 | 20-F/A | 2020-12-31 | AMENDMENT NO. 1 TO FORM 20-F | f20f2020a1_xtlbiopharma.htm |
| 2017-04-03 | 20-F/A | 2016-12-31 | 20-F/A | v463198_20fa.htm |
| 2012-06-11 | 20-F/A | 2011-12-31 | AMENDMENT NO. 2 | v315524_20fa.htm |
| 2012-03-30 | 20-F/A | 2011-12-31 | FORM 20-F/A | v308027_20fa.htm |